BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND uPA AND Diagnosis
5 results:

  • 1. Downregulation of SPINK13 Promotes Metastasis by Regulating upa in ovarian cancer Cells.
    Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
    Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarkers in Breast cancer: Where Are We and Where Are We Going?
    Duffy MJ; Walsh S; McDermott EW; Crown J
    Adv Clin Chem; 2015; 71():1-23. PubMed ID: 26411409
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
    Zhang W; Ling D; Tan J; Zhang J; Li L
    Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors upa and PAI-1 in primary ovarian carcinoma.
    Dorn J; Harbeck N; Kates R; Magdolen V; Grass L; Soosaipillai A; Schmalfeldt B; Diamandis EP; Schmitt M
    Biol Chem; 2006 Aug; 387(8):1121-8. PubMed ID: 16895483
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
    Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
    Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.